Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 65862-921

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 65862-921). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3 (Sevelamer Fig1)

A forest plot chart illustrating change in serum phosphorus (mg/dL) from baseline to Week 2 by subgroup in a clinical study. The chart compares Sevelamer Carbonate versus placebo across various subgroups, including screening BSA, baseline serum phosphorus, age, and dialysis status. The horizontal axis shows mean differences with confidence intervals, centered on a vertical line indicating no difference.*

FDA Label Image

Figure 4 (Sevelamer Fig2)

A line graph showing the percentage of patients achieving various levels of serum phosphorus reduction from baseline treated with Sevelamer Hydrochloride compared to an active control. The X-axis represents the reduction in serum phosphorus (mg/dL), ranging from -4 to 8, and the Y-axis shows the corresponding percentage of patients, from 0% to 100%. The graph illustrates the proportion of patients attaining specific phosphorus reductions with each treatment group.*

FDA Label Image

Package Label-principal Display Panel – 800 mg (30 Tablets Bottle) (Sevelamer Fig3)

A line graph titled 'Mean Phosphorus Change from Baseline for Patients who Completed 52 Weeks of Treatment' showing phosphorus change on the vertical axis and study weeks on the horizontal axis. Two treatment groups, Sevelamer Hydrochloride and Active-Control, are plotted over 52 weeks comparing their phosphorus level changes from baseline.*

FDA Label Image

Sevelamer Fig4

Sevelamer Carbonate Tablets 800 mg film-coated, displayed on a label indicating 30 tablets per container. The label includes the NDC 65862-921-30, ingredients, and distributor details for Aurobindo Pharma USA, Inc., with storage instructions. The label design features a blue-green accent and barcode on the right side.*

FDA Label Image

Chemical Structure (Sevelamer Str)

Chemical structure diagram of Sevelamer Carbonate showing its polymeric structure with labeled primary amine groups, crosslinking groups, and an extended polymer network. The figure includes annotations of molecular components such as NH3+, NH2, NH, OH, and HCO3- groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.